ADL5859

· Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ADL5859, covering 2015-05-07 to 2015-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction [Phase 2]

See pricing